Mutagen-specific mutation signature determines global microRNA binding

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Greenberg, Eyal ^a,b   Rechavi, Gideon ^a,b   Amariglio, Ninette ^a   Solomon, Oz ^a,c   Schachter, Jacob ^a   Markel, Gal ^a,b   Eyal, Eran ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; GUANINE; MICRORNA; OLIGONUCLEOTIDE;

3' UNTRANSLATED REGION; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC REGULATION; HUMAN; LEUKEMIA; LUNG CANCER; NUCLEOTIDE SEQUENCE; RNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM; ULTRAVIOLET RADIATION; ALGORITHM; DNA BASE COMPOSITION; GENETIC DATABASE; GENETICS; METABOLISM; MUTATION; RADIATION EXPOSURE;

3' UNTRANSLATED REGIONS; ALGORITHMS; BASE COMPOSITION; DATABASES, GENETIC; HUMANS; MICRORNAS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; ULTRAVIOLET RAYS;

EID: 80655141612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027400     Document Type: Article

References (56)

1. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, et al. (2011) SEER Cancer Statistics Review, 1975-2008, National Cancer Institute. National Cancer Institute.
2. Bennett DC, (2008) How to make a melanoma: what do we know of the primary clonal events? Pigment Cell Melanoma Res 21: 27-38.
3. Miller AJ, Mihm MC Jr, (2006) Melanoma. N Engl J Med 355: 51-65.
4. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM, et al. (2007) Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 7: 246-255.
5. Patino WD, Susa J, (2008) Epigenetics of cutaneous melanoma. Adv Dermatol 24: 59-70.
6. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
7. Ma L, Weinberg RA, (2008) MicroRNAs in malignant progression. Cell Cycle 7: 570-572.
8. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
9. Friedman RC, Farh KK, Burge CB, Bartel DP, (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
10. Calin GA, (2009) MicroRNAs and cancer: what we know and what we still have to learn. Genome Med 1: 78.
11. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. NatRevGenet 10: 704-714.
12. Di LG, Croce CM, (2010) Roles of small RNAs in tumor formation. Trends MolMed 16: 257-267.
13. Lu J, Getz G, Miska EA, varez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
14. Visone R, Croce CM, (2009) MiRNAs and cancer. AmJPathol 174: 1131-1138.
15. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. ProcNatlAcadSciUSA 103: 2257-2261.
16. Caramuta S, Egyhazi S, Rodolfo M, Witten D, Hansson J, et al. (2010) MicroRNA expression profiles associated with mutational status and survival in malignant melanoma. JInvest Dermatol 130: 2062-2070.
17. Mueller DW, Rehli M, Bosserhoff AK, (2009) miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 129: 1740-1751.
18. Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, et al. (2010) Characterization of the Melanoma miRNAome by Deep Sequencing. PLoSOne 5: e9685.
19. Greenberg E, Hershkovitz L, Itzhaki O, Hajdu S, Nemlich Y, et al. (2011) Regulation of cancer aggressive features in melanoma cells by microRNAs. PLoS One 6: e18936.
20. Chen J, Feilotter HE, Pare GC, Zhang X, Pemberton JG, et al. (2010) MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol 176: 2520-2529.
21. Muller DW, Bosserhoff AK, (2008) Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma. Oncogene 27: 6698-6706.
22. Felicetti F, Errico MC, Bottero L, Segnalini P, Stoppacciaro A, et al. (2008) The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms. Cancer Res 68: 2745-2754.
23. Levy C, Khaled M, Iliopoulos D, Janas MM, Schubert S, et al. (2010) Intronic miR-211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell 40: 841-849.
24. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, et al. (2009) Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A 106: 1814-1819.
25. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T, (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. NatGenet 39: 673-677.
26. Yang Y, Li X, Yang Q, Wang X, Zhou Y, et al. (2010) The role of microRNA in human lung squamous cell carcinoma. Cancer GenetCytogenet 200: 127-133.
27. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, et al. (2006) microRNAs exhibit high frequency genomic alterations in human cancer. ProcNatlAcadSciUSA 103: 9136-9141.
28. Israel A, Sharan R, Ruppin E, Galun E, (2009) Increased microRNA activity in human cancers. PLoSOne 4: e6045.
29. Shah SP, Morin RD, Khattra J, Prentice L, Pugh T, et al. (2009) Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461: 809-813.
30. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, et al. (2009) Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462: 1005-1010.
31. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
32. Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, et al. (2008) DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456: 66-72.
33. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, et al. (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. NEnglJMed 361: 1058-1066.
34. Bueno R, De RA, Dong L, Gordon GJ, Hercus CF, et al. (2010) Second generation sequencing of the mesothelioma tumor genome. PLoSOne 5: e10612.
35. Berger MF, Levin JZ, Vijayendran K, Sivachenko A, Adiconis X, et al. (2010) Integrative analysis of the melanoma transcriptome. Genome Res 20: 413-427.
36. Drobetsky EA, Grosovsky AJ, Glickman BW, (1987) The specificity of UV-induced mutations at an endogenous locus in mammalian cells. ProcNatlAcadSciUSA 84: 9103-9107.
37. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446: 153-158.
38. Wei X, Walia V, Lin JC, Teer JK, Prickett TD, et al. (2011) Exome sequencing identifies GRIN2A as frequently mutated in melanoma. Nat Genet 43: 442-446.
39. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E, (2007) The role of site accessibility in microRNA target recognition. NatGenet 39: 1278-1284.
40. Ottaiano A, De CA, Fazioli F, Talamanca AA, Mori S, et al. (2005) Biological prognostic factors in adult soft tissue sarcomas. Anticancer Res 25: 4519-4526.
41. Curtin JA, Busam K, Pinkel D, Bastian BC, (2006) Somatic activation of KIT in distinct subtypes of melanoma. JClinOncol 24: 4340-4346.
42. Blake J, Ziman MR, (2003) Aberrant PAX3 and PAX7 expression. A link to the metastatic potential of embryonal rhabdomyosarcoma and cutaneous malignant melanoma? Histol Histopathol 18: 529-539.
43. Giehl KA, Nagele U, Volkenandt M, Berking C, (2007) Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma. J Cutan Pathol 34: 7-14.
44. Chen J, Bardes EE, Aronow BJ, Jegga AG, (2009) ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37: W305-311.
45. Friedman Y, Naamati G, Linial M, (2010) MiRror: a combinatorial analysis web tool for ensembles of microRNAs and their targets. Bioinformatics 26: 1920-1921.
46. Bradford PT, (2009) Skin cancer in skin of color. DermatolNurs 21: 170-177, 206.
47. Durbin RM, Abecasis GR, Altshuler DL, Auton A, Brooks LD, et al. (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
48. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, et al. (2011) The UCSC Genome Browser database: update 2011. Nucleic Acids Res 39: D876-D882.
49. Mayr C, Bartel DP, (2009) Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673-684.
50. Hayden EJ, Ferrada E, Wagner A, (2011) Cryptic genetic variation promotes rapid evolutionary adaptation in an RNA enzyme. Nature 474: 92-95.
51. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, et al. (2010) Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 146: 283-287.
52. Sobolewski AL, Domcke W, Hattig C, (2005) Tautomeric selectivity of the excited-state lifetime of guanine/cytosine base pairs: the role of electron-driven proton-transfer processes. Proc Natl Acad Sci U S A 102: 17903-17906.
53. Mailman MD, Feolo M, Jin Y, Kimura M, Tryka K, et al. (2007) The NCBI dbGaP database of genotypes and phenotypes. NatGenet 39: 1181-1186.
54. Enright AJ, John B, Gaul U, Tuschl T, Sander C, et al. (2003) MicroRNA targets in Drosophila. Genome Biol 5: R1.
55. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-D157.
56. Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, et al. (2004) Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64: 5270-5282.